MEDICAL products group Amersham is to be taken over by US conglomerate General Electric in a £5.7bn deal, the companies announced yesterday.
Buckinghamshireshire firm Amersham, which is listed on London's FTSE 100 Index, is a specialist in products for disease detection and medical research.
The offer price of 800p a share represents a premium of more than 45 per cent on the Amersham share price prior to bid speculation earlier this week, when shares in the group rose by a quarter after the approach.
Amersham employs more than 10,000 people worldwide and had sales of £1.6bn last year.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article